Literature DB >> 21424312

[Antibiotic treatment of nosocomial pneumonia].

S Weiterer1, D Störzinger, M Bernhard, K Mayer, C Lass-Flörl, M A Weigand, C Lichtenstern.   

Abstract

Nosocomial pneumonia is one of the most common infectious diseases acquired in hospital and is often caused by resistant pathogens. For treatment of nosocomial pneumonia an appropriate initial antibiotic therapy is essential and exact knowledge of the specific pathogen spectrum is essential for the correct choice of the empirically calculated antibiotics. In line with a critical reevaluation of the primary treatment, pathogen-specific de-escalation therapy, a diagnosis of possible pulmonary complications (e. g. pleural empyema) and the identification and appropriate rehabilitation measures of non-pulmonary infections are necessary. To attain the best possible outcome the respective therapy concept needs to be adjusted to the individual risk characteristics. Appropriate initial antibiotic therapy, duration of mechanical ventilation and comorbidities are the key factors for patient outcome. This approach helps to avoid the development of resistant pathogens and saves economic resources.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424312     DOI: 10.1007/s00101-011-1861-8

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  58 in total

1.  [Nosocomial pneumonia: prevention, diagnosis, treatment].

Authors:  J Lorenz; K-F Bodmann; T T Bauer; S Ewig; M Trautmann; F Vogel
Journal:  Pneumologie       Date:  2003-09

Review 2.  Aerosolized antibiotics to treat ventilator-associated pneumonia.

Authors:  Charles-Edouard Luyt; Alain Combes; Ania Nieszkowska; Jean-Louis Trouillet; Jean Chastre
Journal:  Curr Opin Infect Dis       Date:  2009-04       Impact factor: 4.915

3.  Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia.

Authors:  Elie Azoulay; Jean-François Timsit; Muriel Tafflet; Arnaud de Lassence; Michael Darmon; Jean-Ralph Zahar; Christophe Adrie; Maité Garrouste-Orgeas; Yves Cohen; Bruno Mourvillier; Benoît Schlemmer
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 4.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

5.  Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Thierry Dugernier; Herbert Spapen; Isabelle Delattre; Xavier Wittebole; Daniel De Backer; Brice Layeux; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-07-01       Impact factor: 9.097

Review 6.  Ventilator-associated pneumonia and mortality: a systematic review of observational studies.

Authors:  Wilhelmina G Melsen; Maroeska M Rovers; Marc J M Bonten
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

7.  Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.

Authors:  Nasia Safdar; Jo Handelsman; Dennis G Maki
Journal:  Lancet Infect Dis       Date:  2004-08       Impact factor: 25.071

8.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Authors:  Richard G Wunderink; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Marin H Kollef
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

9.  Early- and late-onset pneumonia: is this still a useful classification?

Authors:  Petra Gastmeier; Dorit Sohr; Christine Geffers; Henning Rüden; Ralf-Peter Vonberg; Tobias Welte
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

Review 10.  [Community-acquired pneumonia].

Authors:  T Welte
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.